Abstract
Despite large improvements in the treatment of coronary artery disease (CAD), it is still the leading cause of death worldwide. The advent of percutaneous coronary intervention (PCI) in clinical practice was a clinical milestone and has dramatically improved the prognosis of patients with acute coronary syndrome (ACS). Although the benefit of this intervention in ACS is clearly established, its role in patients with stable CAD is still under debate. The following review examines the current role of PCI and novel technical developments by summarizing the most relevant studies, carried out under various clinical conditions.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
